ArticleJBRA assisted reproduction2025
Dual Impact of Estradiol Fluctuations in the Final Three Days on IVF/ICSI Outcomes: A Retrospective Cohort Analysis.
Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHow do dynamic changes in serum estradiol (E2) and progesterone (P) concentrations during controlled ovarian hyperstimulation (COS) affect oocyte retrieval and embryo outcomes? What clinical factors drive estradiol elevation in the final three days of stimulation?.
methodsThis single-center retrospective study included 486 first-cycle patients with normal ovarian function undergoing a long protocol in early follicular phase, with fresh embryo transfer. Serum E2 and P concentrations were measured at four time points: the gonadotropin initiation day, four days post-initiation, two days before the hCG trigger, and the day of hCG administration, with different stages, grouped patients by median hormone changes into high-growth and low-growth. Primary and secondary endpoints were ovarian stimulation and pregnancy outcomes, respectively. logistic regressions identified factors associated with estradiol elevation during the last three days of stimulation.
resultsHigh-growth groups had higher oocyte retrieval rates but lower transferable embryo rates. Multivariate analysis identified higher AFCs and mid-cycle estradiol increase as a protective factor (p<0.01). Conversely, higher BMI, higher initial Gn dose (>300 IU) and prolonged stimulation duration were linked to poorer outcomes (p<0.01).
conclusionsDynamic E2/P monitoring provides actionable insights for COS management. Elevated E2 in the late stimulation phase, driven by AFC and mid-cycle hormonal surge, correlates with oocyte yield but requires caution due to reduced embryo utilization. Clinically, excessive gonadotropin dosing and prolonged stimulation should be avoided to optimize outcomes. These findings support personalized hormone adjustment protocols to balance efficacy and safety in ART cycles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.